Novo Nordisk's adjusted Wegovy oral drug sales for the third quarter were DKK 5.39 billion, and the market expected DKK 4.64 billion.

Zhitongcaijing · 11/04 06:41
Novo Nordisk's adjusted Wegovy oral drug sales for the third quarter were DKK 5.39 billion, and the market expected DKK 4.64 billion.